All are used in hyperkalemia except-
**Core Concept**
Hyperkalemia is a condition characterized by elevated levels of potassium ions (K+) in the blood, which can lead to cardiac arrhythmias, muscle weakness, and even respiratory arrest if left untreated. Management of hyperkalemia involves both acute and chronic strategies to reduce serum potassium levels and prevent recurrence.
**Why the Correct Answer is Right**
To manage hyperkalemia, several treatment options are employed, including:
* **Option A:** Insulin and glucose, which helps to drive potassium ions into cells through the Na+/K+-ATPase pump in the cell membrane.
* **Option B:** Beta-2 agonists (e.g., albuterol), which stimulate cellular uptake of potassium ions, thereby lowering serum levels.
* **Option C:** Polystyrene sulfonate (Kayexalate), a cation-exchange resin that binds potassium ions in the gastrointestinal tract and promotes their excretion.
**Why Each Wrong Option is Incorrect**
* **Option D:** Calcium gluconate is actually used in the management of hyperkalemia, but its primary role is to stabilize cardiac membranes and prevent cardiac arrhythmias, rather than lowering serum potassium levels. Its administration does not directly affect potassium ion movement.
**Clinical Pearl / High-Yield Fact**
When managing hyperkalemia, it's essential to remember that beta blockers are contraindicated, as they can worsen cardiac arrhythmias by blocking the protective effects of beta-2 agonists on the heart.
**Correct Answer:** D. Calcium gluconate is used to manage cardiac arrhythmias associated with hyperkalemia, but not to lower serum potassium levels.